Conference Proceedings
EFFICACY AND SAFETY OF AZACITIDINE (AZA) VERSUS CONVENTIONAL TREATMENT (TC) IN PATIENTS=75 YEARS WITH ACUTE MYELOBLASTIC LEUKEMIA (AML) IN THE PHASE III STUDY AZA AML001
J Bargay Lleonart, JF Seymour, R Buckstein, V Santini, H Doehner, RM Stone, MD Minden, Kuo Y Ching, D Ben Yehuda, S Songer, J Weaver, CL Beach, H Dombret
HAEMATOLOGICA | FERRATA STORTI FOUNDATION | Published : 2017
